Elevated salivary alpha-Amylase level, association between depression and disease activity, and stress as a predictor of disease flare in systemic lupus Erythematosus: A prospective case-control study

Medicine (United States)

Volumn 94, Issue 30, 2015, Pages

  Jung, Ju Yang ^a   Nam, Jin Young ^a   Kim, Hyoun Ah ^a   Suh, Chang Hee ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; ANTIBODY; BIOLOGICAL MARKER; CHROMATIN ANTIBODY; HYDROCORTISONE; INTERLEUKIN 1BETA; STRESS HORMONE; UNCLASSIFIED DRUG; ALPHA AMYLASE SALIVA ISOENZYME;

ADRENERGIC SYSTEM; ADULT; ARTICLE; BECK DEPRESSION INDEX; CONTROLLED STUDY; CORTISOL SALIVA LEVEL; DEPRESSION; DEPRESSION ASSESSMENT; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE EXACERBATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; PERCEIVED STRESS SCALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SALIVA LEVEL; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; COMPLICATION; ENZYMOLOGY; FOLLOW UP; METABOLISM; PROGNOSIS; SALIVA; SEVERITY OF ILLNESS INDEX;

ADULT; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PROGNOSIS; PROSPECTIVE STUDIES; QUESTIONNAIRES; SALIVA; SALIVARY ALPHA-AMYLASES; SEVERITY OF ILLNESS INDEX; STRESS, PSYCHOLOGICAL;

EID: 84942431053     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000001184     Document Type: Article

References (43)

1. DCruz DP, Khamashta MA, Hughes GR. Systemic lupus erythematosus. Lancet. 2007;369:587-596.
2. Roussou E, Iacovou C, Weerakoon A, et al. Stress as a trigger of disease flares in SLE. Rheumatol Int. 2013;33:1367-1370.
3. Wick G, Sgonc R, Lechner O. Neuroendocrine-immune disturbances in animal models with spontaneous autoimmune diseases. Ann N Y Acad Sci. 1998;840:591-598.
4. Szyper-Kravitz M, Zandman-Goddard G, Lahita RG, et al. The neuroendocrine-immune interactions in systemic lupus erythematosus: A basis for understanding disease pathogenesis and complexity. Rheum Dis Clin North Am. 2005;31:161-175.
5. Tan IJ, Peeva E, Zandman-Goddard G. Hormonal modulation of the immune system-A spotlight on the role of progestogens. Autoimmun Rev. 2015;14:536-542.
6. Nater UM, Skoluda N, Strahler J. Biomarkers of stress in behavioural medicine. Curr Opin Psychiatry. 2013;26:440-445.
7. Kirschbaum C, Hellhammer DH. Salivary cortisol in psychobiological research: An overview. Neuropsychobiology. 1989;22:150-169.
8. Hellhammer DH, Wust S, Kudielka BM. Salivary cortisol as a biomarker in stress research. Psychoneuroendocrinology. 2009;34:163-171.
9. van Stegeren A, Rohleder N, Everaerd W, et al. Salivary alpha amylase as marker for adrenergic activity during stress: effect of betablockade. Psychoneuroendocrinology. 2006;31:137-141.
10. Berndt C, Strahler J, Kirschbaum C, et al. Lower stress system activity and higher peripheral inflammation in competitive ballroom dancers. Biol Psychol. 2012;91:357-364.
11. Vining RF, McGinley RA, Maksvytis JJ, et al. Salivary cortisol: A better measure of adrenal cortical function than serum cortisol. Ann Clin Biochem. 1983;20:329-335.
12. Kim HA, Jeon JY, Choi GS, et al. The antichromatin antibodies can be useful as a diagnostic tool and disease activity marker of systemic lupus erythematosus in Koreans. Clin Immunol. 2008;128:277-283.
13. Gomez-Puerta JA, Burlingame RW, Cervera R. Anti-chromatin (anti-nucleosome) antibodies: diagnostic and clinical value. Autoimmun Rev. 2008;7:606-611.
14. Bizzaro N, Villalta D, Giavarina D, et al. Are anti-nucleosome antibodies a better diagnostic marker than anti-dsDNA antibodies for systemic lupus erythematosus? A systematic review and a study of meta-Analysis. Autoimmun Rev. 2012;12:97-106.
15. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271-1277.
16. Schubert C, Lampe A, Geser W, et al. Daily psychosocial stressors and cyclic response patterns in urine cortisol and neopterin in a patient with systemic lupus erythematosus. Psychoneuroendocrinology. 2003;28:459-473.
17. Navazesh M. Methods for collecting saliva. Ann N Y Acad Sci. 1993;694:72-77.
18. Lee EH, Chung BY, Suh CH, et al. Korean versions of the Perceived Stress Scale (PSS-14, 10 and 4): psychometric evaluation in patients with chronic disease. Scand J Caring Sci. 2015;29:183-192.
19. Hahn H, Yum T, Shin Y, et al. A standardization study of beck depression inventory in Korea. J Korean Neuropsychiatr Assoc. 1986;25:487-502.
20. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24:385-396.
21. Hewitt PL, Flett GL, Mosher SW. The Perceived Stress Scale: factor structure and relation to depression symptoms in a psychiatric sample. J Psychopathol Behav Assess. 1992;14:247-257.
22. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
23. Malamud D. Saliva as a diagnostic fluid. Dent Clin N Am. 2011;55:159-178.
24. Kang EH, Lee YJ, Hyon JY, et al. Salivary cytokine profiles in primary Sjogrens syndrome differ from those in non-Sjogren sicca in terms of TNF-Alpha levels and Th-1/Th-2 ratios. Clin Exp Rheumatol. 2011;29:970-976.
25. Little FF, Delgado DM, Wexler PJ, et al. Salivary inflammatory mediator profiling and correlation to clinical disease markers in asthma. PLoS ONE. 2014;9:e84449.
26. Zalewska A, Knas M, Niczyporuk M, et al. Salivary lysosomal exoglycosidases profiles in patients with insulin-dependent and noninsulin-dependent diabetes mellitus. Adv Clin Exp Med. 2013;22:659-666.
27. Lisa Cheng YS, Jordan L, Gorugantula LM, et al. Salivary interleukins 6 and 8 in oral cancer patients and in patients with chronic oral inflammatory diseases. J Periodontol. 2014;85:956-965.
28. Pool AJ, Whipp BJ, Skasick AJ, et al. Serum cortisol reduction and abnormal prolactin and CD4/CD8 T-cell response as a result of controlled exercise in patients with rheumatoid arthritis and systemic lupus erythematosus despite unaltered muscle energetics. Rheumatology (Oxford). 2004;43:43-48.
29. van der Goes MC, Bossema ER, Hartkamp A, et al. Cortisol during the day in patients with systemic lupus erythematosus or primary Sjogrens syndrome. J Rheumatol. 2011;38:285-288.
30. Gudbjornsson B, Skogseid B, Oberg K, et al. Intact adrenocorticotropic hormone secretion but impaired cortisol response in patients with active rheumatoid arthritis: effect of glucocorticoids. J Rheumatol. 1996;23:596-602.
31. Harle P, Straub RH, Wiest R, et al. Increase of sympathetic outflow measured by neuropeptide Y and decrease of the hypothalamicpituitary-Adrenal axis tone in patients with systemic lupus erythematosus and rheumatoid arthritis: Another example of uncoupling of response systems. Ann Rheum Dis. 2006;65:51-56.
32. Zietz B, Reber T, Oertel M, et al. Altered function of the hypothalamic stress axes in patients with moderately active systemic lupus erythematosus. II. Dissociation between androstenedione, cortisol, or dehydroepiandrosterone and interleukin 6 or tumor necrosis factor. J Rheumatol. 2000;27:911-918.
33. Kozora E, Ellison MC, Waxmonsky JA, et al. Major life stress, coping styles, and social support in relation to psychological distress in patients with systemic lupus erythematosus. Lupus. 2005;14:363-372.
34. McCracken LM, Semenchuk EM, Goetsch VL. Cross-sectional and longitudinal analyses of coping responses and health status in persons with systemic lupus erythematosus. Behav Med. 1995;20:179-187.
35. Braden CJ, McGlone K, Pennington F. Specific psychosocial and behavioral outcomes from the systemic lupus erythematosus selfhelp course. Health Educ Q. 1993;20:29-41.
36. Ward MM, Marx AS, Barry NN. Psychological distress and changes in the activity of systemic lupus erythematosus. Rheumatology (Oxford). 2002;41:184-188.
37. Greco CM, Rudy TE, Manzi S. Effects of a stress-reduction program on psychological function, pain, and physical function of systemic lupus erythematosus patients: A randomized controlled trial. Arthritis Rheum. 2004;51:625-634.
38. Glaser R, Kiecolt-Glaser JK. Stress-induced immune dysfunction: implications for health. Nat Rev Immunol. 2005;5:243-251.
39. Webster JI, Tonelli L, Sternberg EM. Neuroendocrine regulation of immunity. Annu Rev Immunol. 2002;20:125-163.
40. Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365:2110-2121.
41. Jacob N, Stohl W. Cytokine disturbances in systemic lupus erythematosus. Arthritis Res Ther. 2011;13:228.
42. Banchereau J, Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity. 2006;25:383-392.
43. Karagkouni A, Alevizos M, Theoharides TC. Effect of stress on brain inflammation and multiple sclerosis. Autoimmun Rev. 2013;12:947-953.